Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6347)
All Articles published online
|
Publishing Process of This Article
|
Aug 15, 2013 (publication date) through Jan 30, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pathophysiology
ISSN
2150-5330
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kmira Z, Nesrine BS, Houneida Z, Wafa BF, Aida S, Yosra BY, Monia Z, Sriha B, Abderrahim K. Severe hemorrhagic colitis in a patient with chronic myeloid leukemia in the blastic phase after dasatinib use. World J Gastrointest Pathophysiol 2013; 4(3): 59-62 [PMID: 23946889 DOI: 10.4291/wjgp.v4.i3.59] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v4/i3/59.htm |
| Number | Citing Articles |
| 1 |
Jae-Ki Choi, Sung-Yeon Cho, Su-Mi Choi, Gyo Hui Kim, Sung-Eun Lee, Seok Lee, Dong-Wook Kim, Dong-Gun Lee. Cytomegalovirus Colitis during Dasatinib Treatment for Patients with Hematologic Malignancy: Case Series and Literature Review. Infection & Chemotherapy 2018; 50(2): 153 doi: 10.3947/ic.2018.50.2.153
|
| 2 |
Gabriella Mezei, Ildiko Beke Debreceni, Adrienne Kerenyi, Gyula Remenyi, Robert Szasz, Arpad Illes, Janos Kappelmayer, Peter Batar. Dasatinib inhibits coated-platelet generation in patients with chronic myeloid leukemia. Platelets 2019; 30(7): 836 doi: 10.1080/09537104.2018.1501470
|
| 3 |
Arborea Graziana, Valentini Anna Maria, Marangi Stefania, LT Nicoletta Labarile, Savino Maria Teresa. Dasatinib-Induced Colitis: Risk of misdiagnosis of inflammatory bowel disease. A case report and review of the literature. International Journal of Pharmaceutical Sciences and Developmental Research 2023; 9(1): 006 doi: 10.17352/ijpsdr.000046
|
| 4 |
Roger M. Feakins. Non-Neoplastic Pathology of the Gastrointestinal Tract. 2020; doi: 10.1017/9781316823026
|
| 5 |
Moaath K. Mustafa Ali, Marwa M. Sabha, Kamal H. Al-Rabi. Spontaneous subdural hematoma in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia with normal platelet count after dasatinib treatment. Platelets 2015; 26(5): 491 doi: 10.3109/09537104.2014.935316
|
| 6 |
Mohamed A. Yassin, Abdulqadir J. Nashwan, Ashraf T Soliman, Anil Yousif, Afra Moustafa, Afaf AlBattah, Shehab F. Mohamed, Deena S. Mudawi, Sarah Elkourashy, Deena-Raiza Asaari, Hope-Love G. Gutierrez, Mohamed Almusharaf, Radwa M. Hussein, Abbas H. Moustafa, Hatim El Derhoubi, Sarra Boukhris, Samah Kohla, Nader AlDewik. Cytomegalovirus-induced Hemorrhagic Colitis in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront Therapy. Clinical Medicine Insights: Case Reports 2015; 8 doi: 10.4137/CCRep.S25327
|
| 7 |
Leonardo Campiotti, Elena Bolzacchini, Matteo Basilio Sutter, Andrea Maria Maresca, Anna Maria Grandi, Luigina Guasti. Vitamin D and tyrosine kinase inhibitors in chronic myeloid leukemia. Internal and Emergency Medicine 2018; 13(8): 1337 doi: 10.1007/s11739-018-1957-0
|
| 8 |
Aoife McCarthy, Kieran Sheahan. Non-Neoplastic Pathology of the Gastrointestinal Tract. 2020; : 65 doi: 10.1017/9781316823026.006
|
| 9 |
Naoki Oshima, Yoshiyuki Mishima, Kotaro Shibagaki, Kousaku Kawashima, Norihisa Ishimura, Fumiyoshi Ikejiri, Chie Onishi, Takahiro Okada, Masaya Inoue, Ichiro Moriyama, Junji Suzumiya, Yoshikazu Kinoshita, Shunji Ishihara. Differential gene expression analysis of dasatinib-induced colitis in a patient with chronic myeloid leukemia followed for 3 years: a case report. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-020-01584-6
|
| 10 |
Leonardo Bautista Toloza, Humberto Martínez, Orlando Bonell Patiño. Hematoma intraparenquimatoso del sistema nervioso central asociado con dasatinib en el tratamiento de leucemia mieloide crónica en fase acelerada. Presentación de dos casos y revisión de la literatura. Revista Colombiana de Cancerología 2018; 22(4): 151 doi: 10.1016/j.rccan.2017.10.002
|
| 11 |
Mohammad Muhsin Chisti, Amine Khachani, Govinda R Brahmanday, Justin Klamerus. Dasatinib-induced haemorrhagic colitis in chronic myeloid leukaemia (CML) in blast crisis. BMJ Case Reports 2013; : bcr2013200610 doi: 10.1136/bcr-2013-200610
|
| 12 |
Eunjung Yim, Yeon-Geun Choi, Yoon-Jeong Nam, Jain Lee, Jeong-A Kim. Dasatinib induces severe hemorrhagic colitis in a patient with accelerated phase of chronic myelogenous leukemia. The Korean Journal of Internal Medicine 2018; 33(2): 446 doi: 10.3904/kjim.2015.325
|
| 13 |
Seyyed Javad Boskabadi, Ayat Dashti, Sara Karevan, Saeed Kargar-Soleimanabad, Ebrahim Salehifar. Clinical uses and safety concerns of tyrosine kinase inhibitors with a focus on novel drugs: A narrative review. Journal of Oncology Pharmacy Practice 2023; doi: 10.1177/10781552231174790
|
| 14 |
Jeong Min Kim, Hyun Mi Kang, In Hyuk Yoo, Dong-Gun Lee, Nack-Gyun Chung, Bin Cho. Proven Cytomegalovirus Colitis Associated with Dasatinib Administration in Two Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients. Pediatric Gastroenterology, Hepatology & Nutrition 2023; 26(4): 224 doi: 10.5223/pghn.2023.26.4.224
|
| 15 |
Amlan Kusum Datta, Partha Debnath, Uddalak Chakraborty, Atanu Chandra. Clostridioides difficile-induced diarrhoea following dasatinib therapy. BMJ Case Reports 2021; 14(1): e239394 doi: 10.1136/bcr-2020-239394
|
| 16 |
John B. Bossaer, Stephen A. Geraci, Kanishka Chakraborty. Cardiovascular Toxicity and Management of Targeted Cancer Therapy. The American Journal of the Medical Sciences 2016; 351(5): 535 doi: 10.1016/j.amjms.2016.02.023
|
| 17 |
Mohamed Shanshal, Andrew Shakespeare, Seshadri Thirumala, Boyd Fenton, Donald P. Quick. Dasatinib-Induced T-Cell-Mediated Colitis: A Case Report and Review of the Literature. Acta Haematologica 2016; 136(4): 219 doi: 10.1159/000448983
|
| 18 |
Ibrahim Aldoss, Karl Gaal, Monzr M. Al Malki, Haris Ali, Ryotaro Nakamura, Stephen J. Forman, Vinod Pullarkat. Dasatinib-Induced Colitis after Allogeneic Stem Cell Transplantation for Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation 2016; 22(10): 1900 doi: 10.1016/j.bbmt.2016.06.022
|
| 19 |
Güray Can, Süleyman Ayvaz, Hatice Can, İhsan Karaboğa, Selim Demirtaş, Hasan Akşit, Bülent Yılmaz, Uğur Korkmaz, Mevlüt Kurt, Turan Karaca. The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis. Clinics and Research in Hepatology and Gastroenterology 2016; 40(4): 504 doi: 10.1016/j.clinre.2015.12.006
|
| 20 |
Satoshi Nishiwaki, Matsuyoshi Maeda, Masahiro Yamada, Shingo Okuno, Yasuhiko Harada, Kotaro Suzuki, Shingo Kurahashi, Fumihiro Urano, Shozo Okamura, Isamu Sugiura. Clinical efficacy of fecal occult blood test and colonoscopy for dasatinib-induced hemorrhagic colitis in CML patients. Blood 2017; 129(1): 126 doi: 10.1182/blood-2016-08-734947
|
| 21 |
Roger M Feakins. Morson and Dawson's Gastrointestinal Pathology. 2024; : 709 doi: 10.1002/9781119423195.ch35
|
| 22 |
Alexander Edmund Gluch, Deloshaan Subhaharan, Sooraj Pillai, Pradeep Kakkadasam Ramaswamy. Dasatinib-induced colitis in a patient with chronic myeloid leukaemia. BMJ Case Reports 2025; 18(1): e263646 doi: 10.1136/bcr-2024-263646
|